CordenPharma réalise un investissement record de plus d’un milliard d’euros au cours des trois prochaines années dans la construction et/ou l’expansion de petites, moyennes et grandes installations de fabrication de peptides en Europe et aux États-Unis. En Suisse, CordenPharma investira…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.